From: Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes
 | Univariate | Multivariate | ||
---|---|---|---|---|
Variable | st-β | p | st-β | p |
Age | 0.01 | ns | Â | Â |
Sex | 0.07 | 0.0138 | 0.35 | 0.0002 |
BMI | 0.01 | ns | Â | Â |
Duration of diabetes | − 0.01 | ns |  |  |
HbA1c | − 0.04 | ns |  |  |
Smoke | 0.02 | ns | Â | Â |
Hypertension | 0.02 | ns | Â | Â |
metformin | − 0.01 | ns |  |  |
Creatinine | 0.02 | ns | Â | Â |
ACR (log) | − 1.02 | ns |  |  |
PCR (log) | − 0.50 | ns |  |  |
Hemoglobin | 0.70 | 0.0103 | 0.22 | 0.0133 |
RHI endoPAT | − 0.06 | ns |  |  |
CAVI | 0.20 | ns | Â | Â |
ABI | 0.08 | ns | Â | Â |
MBP peak | − 0.05 | 0.0175 | − 0.02 | ns |
SVR peak | 0.01 |  < 0.0001 | 0.01 | ns |
CO peak | − 0.52 |  < 0.0001 | − 0.30 | ns |
LVEF rest | − 0.01 | ns |  |  |
LVEF peak | 0.01 | ns | Â | Â |
Δ LVEF | 0.10 | ns |  |  |
GLS rest | 0.12 | ns | Â | Â |
GLS 4Â min | 0.34 | 0.0060 | 0.10 | ns |
Δ GLS | 0.19 |  < 0.0001 | 0.21 | 0.0486 |
S’ rest | 0.06 | ns |  |  |
S’ peak | 0.06 | ns |  |  |
Δ S’ | 0.16 | ns |  |  |
E/e’ peak | 0.12 | ns |  |  |
VE/VCO2 slope | − 0.06 | ns |  |  |